PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATES
May 1, 2011, 00:00
10.1016/j.jval.2011.02.655
https://www.valueinhealthjournal.com/article/S1098-3015(11)00794-7/fulltext
Title :
PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00794-7&doi=10.1016/j.jval.2011.02.655
First page :
A118
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
111